✦ LIBER ✦

A multicenter clinical trial of recombinant human GM-CSF hydrogel for the treatment of deep second-degree burns

✍ Scribed by Liping Zhang; Jiong Chen; Chunmao Han

Book ID: 109080647
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 97 KB
Volume: 17
Category: Article
ISSN: 1067-1927
DOI: 10.1111/j.1524-475x.2009.00526.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical trial designed to evaluate th

A clinical trial designed to evaluate the safety and effectiveness of a thermosensitive hydrogel-type cultured epidermal allograft for deep second-degree burns

✍ Yim, Haejun; Yang, Hyeong-Tae; Cho, Yong-Suk; Kim, Dohern; Kim, Jong-Hyun; Chun, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 908 KB

A Randomized and Controlled Multicenter

A Randomized and Controlled Multicenter Prospective Study of the Chinese Medicinal Compound Fufang Xuelian Burn Ointment for the Treatment of Superficial and Deep Second-Degree Burn Wounds

✍ Ouyang, Jing; Chen, Yong-chuan; Luo, Gao-xing; Yan, Hong; Peng, Yi-zhi; Huang, Y 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 306 KB

The effect of a self-assembling peptide

The effect of a self-assembling peptide nanofiber scaffold (peptide) when used as a wound dressing for the treatment of deep second degree burns in rats

✍ Hui Meng; Liyan Chen; Zhaoyang Ye; Songtao Wang; Xiaojun Zhao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 998 KB

## Abstract RADARADARADARADA (RADA16‐I) peptide, consisting of 16 alternating hydrophobic and hydrophilic (also alternating negative and positive charges) amino acids, forms extremely stable β‐pleated sheet structure and then self‐assembles into nanofibers to produce high‐order interwoven nanofiber

Post-partum recurrency rate for clinical

Post-partum recurrency rate for clinical manifestation of human papillomvirus in the ano-genital tract after second trimester laser CO2 treatment: A randomized trial

✍ Gabriele Urban; Partizia Stentella; Ermelinda Baiocco; Paola Scardamaglia; Anton 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB